Literature DB >> 31832691

Alterations of salivary microbial community associated with oropharyngeal and hypopharyngeal squamous cell carcinoma patients.

Madhusmita Panda1, Avdhesh Kumar Rai2, Tashnin Rahman2, Ashok Das2, Rajjyoti Das2, Anupam Sarma2, Amal Ch Kataki2, Indranil Chattopadhyay3.   

Abstract

The highest number (35.1% of global incident cases) of new oropharyngeal (OP) and hypopharyngeal (HP) cancer cases was reported in South-Central Asia. The highest incidence of HP cancer in India was reported in East Khasi Hills District of Meghalaya, Aizawl District of Mizoram, and Kamrup Urban District of Assam. HP and OP cancer showed the highest mortality rate, worst prognoses and the highest rate of nodal metastases and distant metastases. Thus, research is required to detect specific biomarkers for early prevention and diagnosis for these cancers. Oral microbiome signatures in saliva are considered as a potential diagnostic biomarker for OP and HP cancer. Bacterial profile alterations in OP and HP cancer have not been reported in India population, to establish the association of oral bacteria in the progression of OP and HP cancer; we studied bacterial communities in saliva of eight OP and seven HP cancer patients as compared to healthy controls using 16S rRNA V3-V4 region sequencing. The higher abundance of Haemophilus parainfluenzae, Haemophilus influenzae and Prevotella copri and lower abundance of Rothia mucilaginosa, Aggregatibacter segnis, Veillonella dispar, Prevotella nanceiensis, Rothia aeria, Capnocytophaga ochracea, Neisseria bacilliformis, Prevotella nigrescens and Selenomonas noxia in saliva of OP and HP cancer patients may be considered as a non-invasive diagnostic biomarker for OP and HP cancer patients. Streptococcus anginosus may be considered as a non-invasive diagnostic biomarker for OP cancer patients only. Therefore, evaluation of salivary microbial biomarkers may be informative to understand the pathobiology and carcinogenesis of OP and HP cancer.

Entities:  

Keywords:  Biomarkers; Hypopharyngeal cancer; Microbiome; Oropharyngeal cancer; Saliva

Year:  2019        PMID: 31832691     DOI: 10.1007/s00203-019-01790-1

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  6 in total

1.  Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.

Authors:  Avdhesh Kumar Rai; Madhusmita Panda; Ashok Kumar Das; Tashnin Rahman; Rajjyoti Das; Kishore Das; Anupam Sarma; Amal Ch Kataki; Indranil Chattopadhyay
Journal:  Arch Microbiol       Date:  2020-08-11       Impact factor: 2.552

2.  Oropharynx microbiota transitions in hypopharyngeal carcinoma treatment of induced chemotherapy followed by surgery.

Authors:  Hui-Ching Lau; Chi-Yao Hsueh; Hongli Gong; Ji Sun; Hui-Ying Huang; Ming Zhang; Liang Zhou
Journal:  BMC Microbiol       Date:  2021-11-09       Impact factor: 3.605

3.  Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer.

Authors:  Ming-Feng Hou; Fu Ou-Yang; Chung-Liang Li; Fang-Ming Chen; Chieh-Han Chuang; Jung-Yu Kan; Cheng-Che Wu; Shen-Liang Shih; Jun-Ping Shiau; Li-Chun Kao; Chieh-Ni Kao; Yi-Chen Lee; Sin-Hua Moi; Yao-Tsung Yeh; Chien-Ju Cheng; Chih-Po Chiang
Journal:  Exp Mol Med       Date:  2021-10-27       Impact factor: 8.718

4.  Comparative analysis of the oral microbiome of burning mouth syndrome patients.

Authors:  Byeong-Min Lee; Ji Woon Park; Jung Hwan Jo; Bumjo Oh; Gehoon Chung
Journal:  J Oral Microbiol       Date:  2022-03-20       Impact factor: 5.474

Review 5.  Saliva and Oral Diseases.

Authors:  Emanuela Martina; Anna Campanati; Federico Diotallevi; Annamaria Offidani
Journal:  J Clin Med       Date:  2020-02-08       Impact factor: 4.241

6.  Microbial Screening Reveals Oral Site-Specific Locations of the Periodontal Pathogen Selenomonas noxia.

Authors:  Jaydene McDaniel; Steven McDaniel; Beanca Jhanine Samiano; Matthew Marrujo; Karl Kingsley; Katherine M Howard
Journal:  Curr Issues Mol Biol       Date:  2021-06-12       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.